Authors: McFarland, EJ Borkowsky, W Fenton, T Wara, D McNamara, J Samson, P Kang, MH Mofenson, L Cunningham, C Duliege, AM Sinangil, F Spector, SA Jimenez, E Bryson, Y Burchett, S Frenkel, LM Yogev, R Gigliotti, F Luzuriaga, K Livingston, RA

Citation: Ej. Mcfarland et al., Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccine, J INFEC DIS, 184(10), 2001, pp. 1331-1335

Authors: Rothstein, EP Anderson, EL Decker, MD Poland, GA Reisinger, KS Blatter, MM Jacobson, RM Mink, CM Gennevois, D Izu, AE Sinangil, F Langenberg, AGM

Citation: Ep. Rothstein et al., An acellular pertussis vaccine in healthy adults: safety and immunogenicity, VACCINE, 17(23-24), 1999, pp. 2999-3006

Authors: VanCott, TC Mascola, JR Loomis-Price, LD Sinangil, F Zitomersky, N McNeil, J Robb, ML Birx, DL Barnett, S

Citation: Tc. Vancott et al., Cross-subtype neutralizing antibodies induced in baboons by a subtype E gp120 immunogen based on an R5 primary human immunodeficiency virus type 1 envelope, J VIROLOGY, 73(6), 1999, pp. 4640-4650